Pancuronium bromide

Pancuronium.svg

Pancuronium bromide is a neuromuscular-blocking drug or muscle relaxant used in anesthesia to induce muscle paralysis. It is a non-depolarizing agent that works by blocking the action of acetylcholine on nicotinic receptors at the neuromuscular junction.

Mechanism of Action

Pancuronium bromide competes with acetylcholine for binding to nicotinic receptors on the motor endplate of the neuromuscular junction. By inhibiting the action of acetylcholine, it prevents depolarization of the muscle cell membrane, leading to muscle relaxation and paralysis.

Clinical Uses

Pancuronium bromide is primarily used as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is also used in some intensive care units to manage patients requiring prolonged mechanical ventilation.

Pharmacokinetics

Pancuronium bromide is administered intravenously. It has a relatively slow onset of action compared to other neuromuscular-blocking agents, with effects typically seen within 2-3 minutes. The duration of action is approximately 60-90 minutes, depending on the dose and individual patient factors. Pancuronium is metabolized in the liver and excreted primarily by the kidneys.

Side Effects

Common side effects of pancuronium bromide include tachycardia, hypertension, and increased salivation. It may also cause prolonged muscle paralysis and respiratory depression if not properly monitored. Rarely, it can trigger anaphylaxis.

Contraindications

Pancuronium bromide is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with myasthenia gravis, renal impairment, or hepatic impairment.

History

Pancuronium bromide was first synthesized in the 1960s and introduced into clinical practice in the early 1970s. It has since been largely replaced by newer neuromuscular-blocking agents with more favorable pharmacokinetic profiles, such as rocuronium and cisatracurium.

Legal and Ethical Issues

Pancuronium bromide has been used in lethal injection protocols for capital punishment in some jurisdictions. This use has raised significant ethical and legal concerns, particularly regarding the potential for causing pain and suffering if not administered correctly.

See Also

• Neuromuscular-blocking drug
• Anesthesia
• Endotracheal intubation
• Lethal injection
• Rocuronium
• Cisatracurium

External Links

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian